Records 1 - 14
| Matrix metalloproteinase family gene polymorphisms and lung cancer susceptibility: an updated meta-analysis.
Journal of thoracic disease 2020 Mar 12 (3): 349-362.
Li Xiaoliang, Liu Caiyang, Ran Ran, Liu Gaohua, Yang Yanhui, Zhao Wenzhuo, Xie Xiaoyang, Li
| Association of matrix metalloproteinase family gene polymorphisms with lung cancer risk: logistic regression and generalized odds of published data.
Scientific reports 2015 5 10056.
Li Hongxia, Liang Xiaoyan, Qin Xuebing, Cai Shaohua, Yu Senya
| Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients.
BMC cancer 2014 14 (1): 369.
Miao Liyun, Wang Yongsheng, Zhu Suhua, Shi Minke, Li Yan, Ding Jingjing, Yang Jun, Ye Qing, Cai Hourong, Zhang Deping, Liu Hongbing, Song Yo
| Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
Annals of agricultural and environmental medicine : AAEM 2014 21 (3): 546-51.
Brzóska Kamil, Bart?omiejczyk Teresa, Sochanowicz Barbara, Cymerman Magdalena, Grudny Jacek, Ko?akowski Jacek, Kapka-Skrzypczak Lucyna, Kruszewski Marcin, Sliwi?ski Pawe?, Roszkowski-?li? Kazimie
| Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Gene 2013 Jan .
Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J
| Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Dec 33 (6): 1819-28.
Wang Jiying, Cai Yo
| Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.
BMC cancer 2012 Mar 12 (1): 1.
Gonzalez-Arriaga P, Pascual T, Garcia-Alvarez A, Fernandez-Somoano A, Lopez-Cima MF, Tardon A
| Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
Mutagenesis 2010 Jul 25 (4): 371-9.
Peng Bo, Cao Lihuan, Ma Xiaopin, Wang Wenzhang, Wang Dan, Yu Lo
| Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis.
The European respiratory journal 2010 Feb 35 (2): 381-90.
Scherf D B, Dally H, Müller P, Werle-Schneider G, Jäger B, Edler L, Tuengerthal S, Fischer J R, Drings P, Bartsch H, Risch
| Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
International journal of cancer. Journal international du cancer 2009 May 124 (9): 2172-8.
Jin Guangfu, Miao Ruifen, Hu Zhibin, Xu Lin, Huang Xinen, Chen Yijiang, Tian Tian, Wei Qingyi, Boffetta Paolo, Shen Hongbi
| Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
Carcinogenesis 2005 Jun 26 (6): 1117-21.
Zhou Yifeng, Yu Chunyuan, Miao Xiaoping, Wang Yonggang, Tan Wen, Sun Tong, Zhang Xuemei, Xiong Ping, Lin Dongx
| A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma.
Cancer research 2003 Jul 63 (14): 3987-90.
Miao Xiaoping, Yu Chunyuan, Tan Wen, Xiong Ping, Liang Gang, Lu Wenfu, Lin Dongx
| Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
Cancer research 2002 Nov 62 (22): 6430-3.
Yu Chunyuan, Pan Kaifeng, Xing Deyin, Liang Gang, Tan Wen, Zhang Lian, Lin Dongx
| The association of matrix metalloproteinas-2 promoter polymorphisms with lung cancer susceptibility in Taiwan.
The Chinese journal of physiology 0 62 (5): 210-216.
Chen Guan-Liang, Wang Shou-Cheng, Shen Te-Chun, Tsai Chia-Wen, Chang Wen-Shin, Li Hsin-Ting, Wu Cheng-Nan, Chao Che-Yi, Hsia Te-Chun, Bau Da-Ti